Clinical Study to Evaluate the Blood Triglyceride Decreasing Effect and Safety of Korean Post-Fermented Tea Extracts

This study was a 8 week, randomized, multicenter, double-blind, placebo-controlled, parallel-design human trial.

Inclusion criteria

• Male and female subjects older than 19 years old
• Who has fasting blood triglyceride levels ≥ 150 mg/dL
• Who voluntarily agreed to participate in the study and signed an informed consent form

Exclusion criteria

• Those who are taking functional food designed for dyslipidemia reduction within 4 weeks before study participation
• Those who have been diagnosed and are on medication with dyslipidemia, cardiovascular disease, kidney disease, liver disease or thyroid disease within 4 weeks before study participation
• Fasting plasma glucose >126 mg/dL or treatment with medications including oral hypoglycemic agents or insulin
• Who has used or is expected to inevitably use prohibited concomitant medications during the study
• Women who is pregnant /breast-feeding, or who has childbearing potential and does not use available contraceptives
• Who has dosed other study medications within 30 days before screening
• Who is determined ineligible for study participation by investigators for any other reasons